Physician profile
Mary E Zuelzer
NPI 1720148315
$1,801.25
in general payments reported to CMS, 2019-2025
15 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $93.88 · 2021: $111 · 2023: $125 · 2024: $516 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $374.97 | 2023-2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $289.41 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $278.27 | 2019-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $233.80 | 2024 | Spravato |
| Ironshore Pharmaceuticals INC. | $193.85 | 2019-2020 | |
| Abbvie INC. | $124.99 | 2024 | |
| Lundbeck LLC | $53.03 | 2019 | |
| Allergan, INC. | $52.22 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $48.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.03 | 2020-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $35.75 | 2019-2024 | Rexulti, Abilify Maintena |
| Corium, LLC | $21.19 | 2025 | Azstarys |
| Bausch Health US, LLC | $20.49 | 2019 | |
| Shire North American Group INC | $16.50 | 2019 | |
| Adlon Therapeutics L.P. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Zuelzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.